How many studies have been conducted on Filgrastim?

BiohacksAI has indexed 298 PubMed studies on Filgrastim, including 61 randomized controlled trials (RCTs). 80% of studies involve human subjects.

What are the main research areas for Filgrastim?

The primary research domains for Filgrastim are 🔬 Oncology, 😴 Sleep, 🛡️ Immunity. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Filgrastim

A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

298+ PubMed studies analyzed · 61 RCTs · Evidence Score: 57.4

Research Domains

Filgrastim has been studied across 10 research domains including 🔬 Oncology, 😴 Sleep, 🛡️ Immunity, 🔬 Inflammation, 💊 Pain. The primary research focus is 🔬 Oncology with 36% of studies addressing this area.

Loading evidence profile...

This evidence profile for Filgrastim is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.